ACTL6A also interacts with p63 in head and neck squamous cell carcinoma (HNSCC), and activates the Hippo-YAP pathway to control the transcriptional regulation of proliferation and inhibition of differentiation (8). Here, ACTL6A is linked to head and neck squamous cell carcinoma.